Related Experiment Video
Updated: Jan 10, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Cancer-associated snaR-A noncoding RNA interacts with core splicing machinery and disrupts processing of mRNA
Sihang Zhou1, Simon Lizarazo2, Sandip Chorghade3
1Department of Cell and Developmental Biology, University of Illinois Urbana-Champaign, Urbana, IL, USA.
Abstract:
Expansion of RNA polymerase III (Pol III) activity in cancer can activate the transcription of typically silent small RNA genes, including snaR-A (small NF90-associated RNA isoform A), a hominid-specific noncoding RNA that promotes cell proliferation through unclear mechanisms. Here, we show that snaR-A interacts with mRNA splicing factors, including the U2 small nuclear ribonucleoprotein (snRNP) subunit SF3B2, and localizes near subnuclear foci enriched in splicing machinery. Overexpression of snaR-A increases intron retention, a hallmark of inefficient splicing, whereas its depletion enhances splicing of mRNAs characterized by high U2 snRNP occupancy and nuclear speckle proximity. These improvements in splicing coincide with reduced cell proliferation, consistent with tumor-level patterns linking snaR-A to growth in primary cancers. Together, these findings identify snaR-A as a molecular antagonist of splicing and potential disease driver in cancer. We propose that snaR-A-related splicing perturbation may phenocopy splicing defects attributed to U2 snRNP mutations in cancer, eliciting an alternative, non-mutational mechanism of splicing dysregulation during tumorigenesis.
Insights
Small RNA A (snaR-A) promotes cancer cell proliferation by disrupting mRNA splicing. Depleting snaR-A enhances splicing and reduces tumor growth, identifying it as a potential cancer driver.
Area of Science:
- Molecular Biology
- Cancer Research
- RNA Biology
Background:
- Cancer cells exhibit increased RNA polymerase III activity, activating normally silent small RNA genes.
- Small NF90-associated RNA isoform A (snaR-A), a hominid-specific noncoding RNA, is implicated in cancer cell proliferation via unknown mechanisms.
Purpose of the Study:
- To elucidate the mechanisms by which snaR-A influences cell proliferation in cancer.
- To investigate the interaction of snaR-A with cellular machinery involved in mRNA processing.
Main Methods:
- Investigated snaR-A interactions with mRNA splicing factors, including SF3B2, a U2 small nuclear ribonucleoprotein (snRNP) subunit.
- Assessed the impact of snaR-A overexpression and depletion on intron retention and mRNA splicing efficiency.
- Correlated snaR-A levels with cell proliferation rates and splicing characteristics in primary cancers.
Main Results:
- snaR-A interacts with splicing factors and localizes near splicing machinery in subnuclear foci.
- Overexpression of snaR-A leads to increased intron retention, indicating inefficient splicing.
- Depletion of snaR-A enhances splicing of specific mRNAs and reduces cancer cell proliferation.
Conclusions:
- snaR-A acts as a molecular antagonist of mRNA splicing, contributing to cancer progression.
- Dysregulation of splicing by snaR-A represents a novel, non-mutational mechanism driving tumorigenesis.
- snaR-A-mediated splicing perturbation may mimic splicing defects caused by U2 snRNP mutations in cancer.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs

